These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3021068)

  • 1. [A phase II study of UFT in non-small cell lung cancer].
    Shimizu E; Kimura K; Sone S; Inoue I; Nakamura Y; Noda Y; Hojo F; Yagi M; Nakanishi S; Yamasaki K
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2970-3. PubMed ID: 3021068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer.
    Gemma A; Kudoh S; Yoshimura A; Ono Y; Takenaka K; Hayashihara K; Hino M; Shibuya M; Niitani H
    Anticancer Res; 1995; 15(6B):2691-5. PubMed ID: 8669849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical effect of UFT on prostatic cancer].
    Naito K; Hisazumi H; Misaki T; Shimada K; Miyazaki K; Kosaka S; Miyagi T
    Gan To Kagaku Ryoho; 1985 Jul; 12(7):1440-4. PubMed ID: 3925886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase II study of UFT for head and neck cancer].
    Inuyama Y; Takeda C; Miyake H; Fujii M; Tanaka J; Hirokawa T; Ooyama W; Horiuchi M; Uchida M; Kaneko S
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):479-84. PubMed ID: 3923939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of uracil-tegafur plus cisplatin in patients with previously untreated advanced non-small cell lung cancer.
    Takayama K; Kawasaki M; Ninomiya K; Motohiro A; Fujita M; Watanabe K; Kajiki A; Iwami F; Miyazaki N; Izumi M; Hara N; Nakanishi Y;
    Respirology; 2008 Jan; 13(1):103-7. PubMed ID: 18197918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chemotherapy with cisplatin and daily administration of UFT for unresectable non-small cell lung cancer].
    Takanashi N; Hara N; Ichinose Y; Asoh H; Yano T; Yokoyama H; Miura T; Matsuoka Y; Tayama K; Ohta M
    Gan To Kagaku Ryoho; 1993 May; 20(7):921-7. PubMed ID: 8387761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer.
    Imaizumi M;
    Lung Cancer; 2005 Jul; 49(1):85-94. PubMed ID: 15949594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer.
    Hamada C; Tanaka F; Ohta M; Fujimura S; Kodama K; Imaizumi M; Wada H
    J Clin Oncol; 2005 Aug; 23(22):4999-5006. PubMed ID: 16051951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dramatic response to uracil-tegafur (UFT) in an elderly patient with nonsmall cell lung cancer.
    Kanaji N; Bandoh S; Ishida T
    South Med J; 2007 Oct; 100(10):1056-7. PubMed ID: 17943058
    [No Abstract]   [Full Text] [Related]  

  • 12. A phase I study of UFT/leucovorin, carboplatin, and paclitaxel in combination with external beam radiation therapy for advanced esophageal carcinoma.
    Czito BG; Cohen DP; Kelsey CR; Lockhart AC; Bendell JC; Willett CG; Petros WP; D'Amico TA; Truax R; Hurwitz HI
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1066-72. PubMed ID: 17881149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Report on nationwide pooled data and cohort investigation in UFT phase II study].
    Ota K; Taguchi T; Kimura K
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2749-57. PubMed ID: 3115185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combination chemotherapy with continuous infusion of low-dose cisplatin and UFT for advanced non-small cell lung cancer].
    Seike M; Andoh M; Hasegawa K; Sakonji M; Tsuboi E
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1539-42. PubMed ID: 9725046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinoma.
    Ikeda M; Okusaka T; Ueno H; Morizane C; Furuse J; Ishii H
    Jpn J Clin Oncol; 2005 Aug; 35(8):439-43. PubMed ID: 16024530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-1 plus cisplatin combination chemotherapy in patients with advanced non-small cell lung cancer: a multi-institutional phase II trial.
    Ichinose Y; Yoshimori K; Sakai H; Nakai Y; Sugiura T; Kawahara M; Niitani H
    Clin Cancer Res; 2004 Dec; 10(23):7860-4. PubMed ID: 15585618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical results of treatment with the UFT fine granule preparation under cooperative study. Tokyo Cancer Chemotherapy Cooperative Study Group].
    Futatsuki K; Komita T; Kamano T; Watanabe H
    Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1274-80. PubMed ID: 3107478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of a phase II trial of high-dose radiotherapy (60 Gy) and UFT/l-leucovorin in patients with non-resectable locally advanced rectal cancer (LARC).
    Vestermark LW; Jacobsen A; Qvortrup C; Hansen F; Bisgaard C; Baatrup G; Rasmussen P; Pfeiffer P
    Acta Oncol; 2008; 47(3):428-33. PubMed ID: 18348002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [UFT plus cisplatin with concurrent radiotherapy in unresectable stage III non-small cell lung cancer--its application to outpatient practice].
    Yano T; Koga T; Nomiyama H; Hidaka H
    Gan To Kagaku Ryoho; 2003 Jul; 30(7):959-62. PubMed ID: 12894710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
    Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.